Updating Coverage Report: Two Binary Events Rapidly Approaching Principal Solar (PSWW).
Electric Vehicle EV Engine ‘Retro-Fitting’ Company Nearing Commercialization
Minerva Oil Field Deal Valued at $116 Million, Nearing...
Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.
Think Equity: Society Pass (Nasdaq: SOPA) – Path to Profitability
NEW YORK, NY, March 14, 2023 (GLOBE NEWSWIRE) --...
IA Initiates Analyst Coverage of Principal Solar (Press Release).
Principal Solar, Inc.Mon, March 20, 2023 at 7:30 AM EDT
Institutional Analyst, Inc....
New Player in the Electric Vehicle (EV) Market?
Principal Solar (PSWW) Highlights one of it's Portfolio Holdings, eTruck Transportation.
Alternative Energy...
Institutional Analyst: Our #1 Internet Company, Society Pass (Nasdaq: SOPA), Holds Appeal for Both...
Press Release:
February 28, 2023 07:30 ET | Source: Society Pass Incorporated
New York,...
New Report: Society Pass (SOPA), Our #1 Internet Company Trading Under $5.00.
Our #1 Internet Company Trading Under $5.00, Society Pass Holds Appeal for Both Traders and Long-Term Investors.
Initiating Coverage on Society Pass (SOPA).
Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
Society Pass (SOPA) Research Reports
RESEARCH REPORT ARCHIVE
Maxim Capital Group
NEW YORK, NY, April 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –...
Smart For Life (SMFL) $0.37 Announces Initiation of Equity Analyst Coverage by Dawson James...
Initiates with “Buy” recommendation and $8 price target.
MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Smart for Life,...
Report: Kerrisdale Capital on Up Fintech Holding (TIGR).
The Robinhood of China? If They Liked it at $18, They've got to Love it at $4.00!
Latest article
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
